Dongsung Pharmaceutical Says Two Executives Referred to Prosecutors Over Embezzlement Allegations

• Dongsung Pharmaceutical's Nov. 6, 2026, correction disclosed police referred its CEO and a registered director to prosecutors on embezzlement allegations.
• Allegations against another registered director were dismissed.
• The complaint alleged KRW 17.73 billion in embezzlement, equivalent to 30.6% of equity; the amount remains unconfirmed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dongsung Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261106800952), on November 06, 2026, and is solely responsible for the information contained therein.